311 related articles for article (PubMed ID: 33515704)
41. O-GlcNAcylation stabilizes β-catenin through direct competition with phosphorylation at threonine 41.
Olivier-Van Stichelen S; Dehennaut V; Buzy A; Zachayus JL; Guinez C; Mir AM; El Yazidi-Belkoura I; Copin MC; Boureme D; Loyaux D; Ferrara P; Lefebvre T
FASEB J; 2014 Aug; 28(8):3325-38. PubMed ID: 24744147
[TBL] [Abstract][Full Text] [Related]
42. Regulation of cardiac O-GlcNAcylation: More than just nutrient availability.
Collins HE; Chatham JC
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165712. PubMed ID: 32014551
[TBL] [Abstract][Full Text] [Related]
43. The role and potential mechanism of O-Glycosylation in gastrointestinal tumors.
Zhou F; Ma J; Zhu Y; Wang T; Yang Y; Sun Y; Chen Y; Song H; Huo X; Zhang J
Pharmacol Res; 2022 Oct; 184():106420. PubMed ID: 36049664
[TBL] [Abstract][Full Text] [Related]
44. The effects of O-GlcNAc alteration on Alzheimer-like neurodegeneration in SK-N-SH cells.
Ding N; Peng P; Chu YJ; Wang JJ; Chen SY; Arulthas R; Deng YQ
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Sep; 162(3):243-248. PubMed ID: 30181664
[TBL] [Abstract][Full Text] [Related]
45. Regulating the Regulators: Mechanisms of Substrate Selection of the O-GlcNAc Cycling Enzymes OGT and OGA.
Stephen HM; Adams TM; Wells L
Glycobiology; 2021 Aug; 31(7):724-733. PubMed ID: 33498085
[TBL] [Abstract][Full Text] [Related]
46. Increased O-GlcNAc levels correlate with decreased O-GlcNAcase levels in Alzheimer disease brain.
Förster S; Welleford AS; Triplett JC; Sultana R; Schmitz B; Butterfield DA
Biochim Biophys Acta; 2014 Sep; 1842(9):1333-9. PubMed ID: 24859566
[TBL] [Abstract][Full Text] [Related]
47. Sustained
Tan EP; McGreal SR; Graw S; Tessman R; Koppel SJ; Dhakal P; Zhang Z; Machacek M; Zachara NE; Koestler DC; Peterson KR; Thyfault JP; Swerdlow RH; Krishnamurthy P; DiTacchio L; Apte U; Slawson C
J Biol Chem; 2017 Sep; 292(36):14940-14962. PubMed ID: 28739801
[TBL] [Abstract][Full Text] [Related]
48. Chemical tools to probe cellular O-GlcNAc signalling.
Ostrowski A; van Aalten DM
Biochem J; 2013 Nov; 456(1):1-12. PubMed ID: 24156473
[TBL] [Abstract][Full Text] [Related]
49. Functional significance of O-GlcNAc modification in regulating neuronal properties.
Hwang H; Rhim H
Pharmacol Res; 2018 Mar; 129():295-307. PubMed ID: 29223644
[TBL] [Abstract][Full Text] [Related]
50. Potential coordination role between O-GlcNAcylation and epigenetics.
Wu D; Cai Y; Jin J
Protein Cell; 2017 Oct; 8(10):713-723. PubMed ID: 28488246
[TBL] [Abstract][Full Text] [Related]
51. Demystifying O-GlcNAcylation: hints from peptide substrates.
Shi J; Ruijtenbeek R; Pieters RJ
Glycobiology; 2018 Nov; 28(11):814-824. PubMed ID: 29635275
[TBL] [Abstract][Full Text] [Related]
52. O-GlcNAcase: Emerging Mechanism, Substrate Recognition and Small-Molecule Inhibitors.
Elbatrawy AA; Kim EJ; Nam G
ChemMedChem; 2020 Jul; 15(14):1244-1257. PubMed ID: 32496638
[TBL] [Abstract][Full Text] [Related]
53. Gene expression of O-GlcNAc cycling enzymes in human breast cancers.
Krześlak A; Forma E; Bernaciak M; Romanowicz H; Bryś M
Clin Exp Med; 2012 Mar; 12(1):61-5. PubMed ID: 21567137
[TBL] [Abstract][Full Text] [Related]
54. Dexamethasone-Induced Skeletal Muscle Atrophy Increases O-GlcNAcylation in C2C12 Cells.
Massaccesi L; Goi G; Tringali C; Barassi A; Venerando B; Papini N
J Cell Biochem; 2016 Aug; 117(8):1833-42. PubMed ID: 26728070
[TBL] [Abstract][Full Text] [Related]
55. In Vitro Biochemical Assays for O-GlcNAc-Processing Enzymes.
Kim EJ
Chembiochem; 2017 Aug; 18(15):1462-1472. PubMed ID: 28474822
[TBL] [Abstract][Full Text] [Related]
56. Deficiency in intestinal epithelial O-GlcNAcylation predisposes to gut inflammation.
Zhao M; Xiong X; Ren K; Xu B; Cheng M; Sahu C; Wu K; Nie Y; Huang Z; Blumberg RS; Han X; Ruan HB
EMBO Mol Med; 2018 Aug; 10(8):. PubMed ID: 29941542
[TBL] [Abstract][Full Text] [Related]
57. High-fat diet increases O-GlcNAc levels in cerebral arteries: a link to vascular dysfunction associated with hyperlipidaemia/obesity?
Lima VV; Giachini FR; Matsumoto T; Li W; Bressan AF; Chawla D; Webb RC; Ergul A; Tostes RC
Clin Sci (Lond); 2016 Jun; 130(11):871-80. PubMed ID: 26929437
[TBL] [Abstract][Full Text] [Related]
58. O-GlcNAc modification affects the ATM-mediated DNA damage response.
Miura Y; Sakurai Y; Endo T
Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
[TBL] [Abstract][Full Text] [Related]
59. Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro.
Zhang N; Chen X
Biotechnol Appl Biochem; 2016 Nov; 63(6):841-851. PubMed ID: 26333304
[TBL] [Abstract][Full Text] [Related]
60. O-GlcNAcylation: roles and potential therapeutic target for bone pathophysiology.
Yan X; Zheng J; Ren W; Li S; Yang S; Zhi K; Gao L
Cell Commun Signal; 2024 May; 22(1):279. PubMed ID: 38773637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
